Research Trial for Hand Eczema (22 Weeks)

Adults aged 18 years or older with a diagnosis of chronic hand eczema that has persisted for more than 3 months or returned twice or more within the last 12 months, may qualify to participate. Individuals must have moderate to severe disease, as well as a documented recent history of inadequate response to treatment with topical corticosteroids (at any time within 1 year before the screening visit) or for whom topical corticosteroids are documented to be otherwise medically inadvisable (e.g. due to important side effects or safety risks). Individuals will be asked to complete an eDiary on a daily basis and assess the worst severity of 6 individual signs and symptoms (itch, pain, cracking, redness, dryness, flaking) over the past 24 hours, throughout the trial.

Participants will receive investigational medication (active study drug) or placebo, via a cream. Study medication and study-related procedures will be provided at no cost. Reimbursement for study-related expenses will also be provided.

Study participation will last about 22 weeks and involve about 9 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more